Rankings
▼
Calendar
CLDX FY 2018 Earnings — Celldex Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CLDX
Celldex Therapeutics, Inc.
$2B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$10M
-25.2% YoY
Gross Profit
-$57M
-596.7% margin
Operating Income
-$156M
-1640.1% margin
Net Income
-$151M
-1585.1% margin
EPS (Diluted)
$-14.48
Cash Flow
Operating Cash Flow
-$75M
Free Cash Flow
-$76M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$156M
Total Liabilities
$32M
Stockholders' Equity
$124M
Cash & Equivalents
$24M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$10M
$13M
-25.2%
Gross Profit
-$57M
-$83M
+31.8%
Operating Income
-$156M
-$122M
-28.7%
Net Income
-$151M
-$93M
-62.5%
← Q4 2017
All Quarters
Q1 2018 →